Variable | Median (25th and 75th percentiles)/ Number (%) | ||||
---|---|---|---|---|---|
Total (N = 80) | Survived (N = 22) | Passed away (N = 58) | P-Value | ||
Age (years) | 67(58.25-74) | 70.50(63.50-76.25) | 64(58-72.25) | 0.085 | |
Sex | Female | 26 (32.5) | 6 (27.3) | 20 (34.5) | 0.53 |
Male | 54 (67.5) | 16 (72.7) | 38 (65.5) | ||
History of chemotherapy | Yes | 24 (30) | 7 (31.8) | 17 (29.3) | 0.82 |
No | 56 (70) | 15 (68.2) | 41 (70.7) | ||
Types of Extrahepatic CCA | Distal and proximal of CBD | 69 (86.3) | 18 (81.8) | 51 (87.9) | 0.478 |
PeriHilar | 11 (100) | 4 (36.4) | 7 (63.6) | 0.366 | |
AST (units/L) | 84.50(54-146.50) | 62(36.50-97.25) | 98(63.75-156.75) | 0.007 | |
ALT (units/L) | 76(46.25-129.25) | 58.50(29.25–113.20) | 87(50-140.50) | 0.080 | |
ALP (units/L) | 1032.50(511-1426.25) | 670(413.75–1193) | 1098(601.25-1484.25) | 0.111 | |
Bil T (mg/dL) | 12.62(5.30-24.23) | 10.31(2.97–19.80) | 12.97(5.68–25.18) | 0.298 | |
Bil.D (mg/dL) | 7(3–13) | 7(1.88–13.73) | 7.30(3.30–13.30) | 0.605 | |
ALB (g/l) | 2.8(2.2–3.48) | 3.10(2.70–3.79) | 2.50(2.10–3.40) | 0.06 | |
WBC | 8300(67000 − 11000) | 7000(6280–8250) | 8900 (7150–11975) | 0.005 | |
NEU | 5967.9(4722.9-9215.7) | 5020(4481-6356.1) | 6759.7(4929.6-9842.8) | 0.016 | |
Lymph | 1273.2(879.3-1584.5) | 1286.9(1058.3-1519.5) | 1273.2(852.5-1666.5) | 0.906 | |
PLT | 251,000(196500–330250) | 211,000(178500–343250) | 268,000(217000–318750) | 0.090 | |
PT | 13.70(13.13–15.45) | 13.50(12-14.55) | 13.90(13.50-15.93) | 0.191 | |
INR | 1.07(1-1.30) | 1.01(1-1.11) | 1.10(1-1.48) | 0.043 | |
ALB/Bili ratio | (0.23(0.13–0.44) | 0.29(0.14–0.95) | 0.20(0.12–0.38) | 0.143 | |
NEU/Lymph ratio | (4.44(3.18–9.26) | 3.78(2.96–6.07) | 4.97(3.29–10.03) | 0.101 | |
PLT/Lymph ratio | 96.7(130.9-328.6) | 174.3(129.9-278.5) | 210.7(130.8-340.1) | 0.055 | |
ALBI score | -1.64(-2.42- -1.19) | -1.92(-2.67- -1.66) | -1.41(-2.19- -1.12) | 0.012 | |
ALBI Grades | Grade 1 (%) | 15 (18.8) | 6 (27.3) | 9 (15.5) | 0.01 |
Grade 2 (%) | 34 (42.5) | 13 (59.1) | 21 (36.2) | ||
Grade 3 (%) | 31 (38.8) | 3 (13.6) | 28 (48.3) |